Research ArticleArticles
Open Access
Clinical Pharmacokinetics and the Impact of Genetic Polymorphism on a CYP2C19 Substrate, BMS-823778, in Healthy Subjects
Jiachang Gong, Lars Hansen and Lisa Iacono
Drug Metabolism and Disposition March 2018, 46 (3) 316-325; DOI: https://doi.org/10.1124/dmd.117.078824
Jiachang Gong
Pharmaceutical Candidate Optimization (J.G.), Innovative Clinical Development CFI (L.H.), and Global Regulatory Safety and Biometrics (L.I.), Bristol-Myers Squibb, Princeton, New Jersey
Lars Hansen
Pharmaceutical Candidate Optimization (J.G.), Innovative Clinical Development CFI (L.H.), and Global Regulatory Safety and Biometrics (L.I.), Bristol-Myers Squibb, Princeton, New Jersey
Lisa Iacono
Pharmaceutical Candidate Optimization (J.G.), Innovative Clinical Development CFI (L.H.), and Global Regulatory Safety and Biometrics (L.I.), Bristol-Myers Squibb, Princeton, New Jersey
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticles
BMS-823778 Pharmacokinetics, Impact of Genetic Polymorphism
Jiachang Gong, Lars Hansen and Lisa Iacono
Drug Metabolism and Disposition March 1, 2018, 46 (3) 316-325; DOI: https://doi.org/10.1124/dmd.117.078824
Jump to section
Related Articles
Cited By...
More in this TOC Section
Articles
Similar Articles
Advertisement